Green Spring Technology's High-Stability Standardized Feverfew Extract Significantly Enhances Bioavailability

Recently, Green Spring Technology, a leading domestic plant-based ingredient company, announced the successful development of a highly stable standardized feverfew extract through innovative delivery technology and modified processing techniques. This breakthrough significantly enhances the bioavailability of the product's primary active components. The advancement is poised to deliver a new generation of highly effective, stable natural ingredient solutions for functional foods, dietary supplements, and premium skincare, driving product upgrades and innovation across the industry.

Deepening Expertise in Natural Ingredients, Overcoming Application Challenges

Feverfew (Tanacetum parthenium), a traditional herb, boasts a medicinal history dating back to multiple ancient civilizations. Modern research indicates its core active component—parthenolide (PTL)—belongs to the sesquiterpene lactone class of compounds. Possessing a key active center, the α-methyl-γ-lactone ring, parthenolide demonstrates broad biological regulatory potential. However, despite its remarkable efficacy potential, parthenolide has long faced practical application challenges including low water solubility, poor stability, and inefficient bioavailability. These limitations severely hinder industrial development and product performance.

Green Spring Technology's R&D team systematically tackled this industry-wide challenge. Through optimized extraction and purification processes, the team achieved highly efficient enrichment of paracymene, consistently meeting and exceeding international standards (>0.20%). Crucially, the team leveraged multiple cutting-edge technologies, including liposome encapsulation and structural derivative synthesis.

Technological Innovation Drives Ingredient Modification, with Liposome Technology as the Key Breakthrough

Among these technologies, liposome encapsulation plays a central role. This technique utilizes highly biocompatible phospholipid bilayers to construct microsphere carriers, encapsulating apigenin molecules within them. This protects the compound from environmental degradation, significantly enhancing its stability. Simultaneously, leveraging liposomes' excellent fusion properties with cell membranes, the encapsulated extract is absorbed more efficiently by the human body, markedly improving bioavailability.

Furthermore, Green Spring Technology has successfully developed a series of structural derivatives, including dimethylamino-p-terpineol (DMAPT). By selectively introducing hydrophilic groups into the parent structure, the raw material's solubility and metabolic properties are effectively enhanced without compromising the functionality of its active center.

Broad Application Scope, Infusing New Momentum into Product Innovation

With its breakthrough improvements in solubility and stability, Green Spring Technology's high bioavailability Feverfew Extract significantly expands its application scenarios. In the functional food and dietary supplement sectors, it can be widely used in sleep-aid, mood management, antioxidant, and immune support products. Whether in capsules, tablets, or functional beverages, it maintains excellent ingredient stability and release performance.

Its superior transdermal absorption and antioxidant properties offer a potent, natural ingredient option for developing anti-aging, soothing, and restorative skincare products, aligning with the market's dual pursuit of “clean beauty” and “scientifically formulated” solutions.

Driving Industry Synergy: Green Spring Technology Committed to Comprehensive Natural Ingredient Solutions

Green Spring Technology remains dedicated to the deep development and industrial application of medicinal and edible plant resources. The launch of this highly stable white Feverfew Extract not only demonstrates the company's technological prowess but also reflects its precise insight into market demands. The company has established production lines compliant with international standards, capable of meeting diverse customer needs from sample orders to large-scale production.

Looking ahead, Green Spring Technology pledges to intensify R&D investments in plant bioactive extraction, modification, and delivery systems. Through close collaboration with universities, research institutes, and industry brands, the company will drive innovation and advancement in China's natural health ingredients sector, delivering more high-quality raw material solutions that are “sourced from nature and grounded in science.”

Industry clients and partners are invited to inquire and discuss technical specifications, application solutions, and market collaboration details for our highly stable white Feverfew Extract. Contact us at helen@greenspringbio.com or WhatsApp: +86 13649243917 to harness the dual power of science and nature for your next generation of health products.

References

[1] Zhang T. Experimental study on the antitumor effect of parthenolide[D]. Tianjin: Tianjin Polytechnic University, 2005.

[2] Zhou H Q. Research progress on the biological properties and pharmacological effects ofparthenolide [J]. Chinese Journal of New Drugs, 2009, 18(20): 1954-1957.

[3] Huang Chuyang, Yang Chao. Experimental study on the anti-tumor mechanism of parthenolide[D]. Shenyang: China Medical University, 2010.

[4] Zhang Tu, Song Xiaokai. Effects of small parthenolide on the expression of p53 protein and proliferating cell nuclear antigen in human liver cancer BEL-7402 cells [J]. Chinese Herbal Medicine, 2005, 36 (12): 1850-1852.